Nerandomilast, an oral treatment being developed by Boehringer Ingelheim, bested a placebo at preserving lung function in adults with progressive pulmonary fibrosis in a Phase 3 study, according to top-line data announced by the company. With those results, nerandomilast met the primary endpoint, or goal, of the study,…
Have you seen the T-shirt or sign that reads “Keep Calm and Carry On” (KCCO)? You might be surprised to learn the story behind this phrase. Created in 1939, it was part of a three-poster series intended to boost morale during World War II. Ironically, the Keep Calm…
Low total cholesterol levels are linked to a higher risk of death among people with idiopathic pulmonary fibrosis, a new study from China with more than three years of follow-up data found. “We conducted a long-term follow-up study in patients with IPF and observed that lower [total cholesterol] levels…
Exercise is important for people with chronic illness. But as someone living with idiopathic pulmonary fibrosis (IPF), a disease characterized by progressive scarring of the lungs and difficulty breathing, I know working out is easier said than done. I’ve also found some strategies that make it easier for me.
We’re not all the same. When I share details about my journey with idiopathic pulmonary fibrosis (IPF), I don’t want to give the impression that I’m setting a standard. My goal in writing this column is to share my experiences, which may or may not be similar to others.
An imbalance in gene activity within two types of immune cells explains why idiopathic pulmonary fibrosis (IPF) progresses but in people who develop lung fibrosis after a severe COVID-19 infection, their lungs get better, a new study finds. Researchers showed mortality risk in IPF and COVID-19 was tied to…
Grief is a universally understood emotion. How that emotion is individually expressed is unique. When I was diagnosed with idiopathic pulmonary fibrosis (IPF), I was 59 years old. I’d experienced loss by then, both family and friends. I cannot bundle grief. In my own unique style, I grieve…
Mediar Therapeutics is planning to launch a Phase 2 clinical trial to test its experimental therapy MTX-463 in people with idiopathic pulmonary fibrosis (IPF). The company has entered into a global licensing agreement with Eli Lilly to advance the development of MTX-463. Mediar will be responsible for…
How big is the internet? I could just say that it’s big, but I want to provide some facts to shed additional light on the topic. According to Health IT, the internet is anticipated to reach 175 zettabytes in size in 2025. In my world, I deal in gigabytes on…
Broadway performers will sing show tunes at the 15th annual Pulmonary Fibrosis Foundation Broadway Belts for PFF! event, which will be held at New York’s Sony Hall March 10 to raise funds and awareness for pulmonary fibrosis, a disease in which scar tissue forms in the lungs. Tony…
Get regular updates to your inbox.
